BlackRock Fund Advisors’s Abiomed Inc ABMD Stock Holding History

BlackRock Fund Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$185M	Buy	1,640,991 +9,112	+0.6%	+$1.06M	0.03%	718
2016 Q3	$210M	Buy	1,631,879 +66,809	+4%	+$8M	0.04%	511
2016 Q2	$171M	Sell	1,565,070 -539,287	-26%	-$53.7M	0.04%	588
2016 Q1	$200M	Sell	2,104,357 -524,605	-20%	-$44.3M	0.05%	492
2015 Q4	$237M	Buy	2,628,962 +133,319	+5%	+$11.3M	0.05%	396
2015 Q3	$231M	Buy	2,495,643 +121,155	+5%	+$10.7M	0.06%	369
2015 Q2	$156M	Buy	2,374,488 +42,308	+2%	+$2.81M	0.04%	635
2015 Q1	$167M	Buy	2,332,180 +122,968	+6%	+$6.67M	0.04%	604
2014 Q4	$84.1M	Buy	2,209,212 +220,538	+11%	+$6.96M	0.02%	1079
2014 Q3	$49.4M	Sell	1,988,674 -20,160	-1%	-$511K	0.01%	1362
2014 Q2	$50.5M	Sell	2,008,834 -79,519	-4%	-$1.85M	0.01%	1386
2014 Q1	$54.4M	Buy	2,088,353 +47,129	+2%	+$1.3M	0.02%	1351
2013 Q4	$54.6M	Sell	2,041,224 -91,160	-4%	-$2.25M	0.02%	1335
2013 Q3	$40.6M	Buy	2,132,384 +210,650	+11%	+$4.82M	0.01%	1489
2013 Q2	$41.4M	Buy	+1,921,734	New	+$38.6M	0.02%	1364

Other funds holding ABMD

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BlackRock Fund Advisors's ABMD Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Abiomed Inc (ABMD) stake by 0.56% in Q4 2016, buying an estimated $1.06M and bringing the position to 1,640,991 shares worth $185M. The position accounts for 0.03% of the portfolio, ranked #718.

BlackRock Fund Advisors first reported a position in ABMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $237M in Q4 2015. 297 funds tracked by Wall St. Rank hold ABMD as of Q4 2016.

BlackRock Fund Advisors held 1,640,991 shares of Abiomed Inc worth $185M as of Q4 2016.
BlackRock Fund Advisors bought 9,112 Abiomed Inc shares in Q4 2016, an estimated $1.06M.
Abiomed Inc made up 0.03% of BlackRock Fund Advisors's portfolio in Q4 2016, its #718 holding.
BlackRock Fund Advisors first reported a position in Abiomed Inc in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Abiomed Inc position peaked at $237M in Q4 2015.
297 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.